ConductScience.org, home

Trial · NCT01306942

Participant flow24

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Phase ISTARTEDDasatinib 100mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m26
Phase ISTARTEDDasatinib 140mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m24
Phase ISTARTEDDasatinib 70mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m20
Phase ISTARTEDPhaseII Dasatinib 100mg/Trastuzumab 2mg/kg/Paclitaxel 80mg/m20
Phase ICOMPLETEDDasatinib 100mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m21
Phase ICOMPLETEDDasatinib 140mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m21
Phase ICOMPLETEDDasatinib 70mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m20
Phase ICOMPLETEDPhaseII Dasatinib 100mg/Trastuzumab 2mg/kg/Paclitaxel 80mg/m20
Phase INOT COMPLETEDDasatinib 100mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m25
Phase INOT COMPLETEDDasatinib 140mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m23
Phase INOT COMPLETEDDasatinib 70mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m20
Phase INOT COMPLETEDPhaseII Dasatinib 100mg/Trastuzumab 2mg/kg/Paclitaxel 80mg/m20
Phase IISTARTEDDasatinib 100mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m22
Phase IISTARTEDDasatinib 140mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m20
Phase IISTARTEDDasatinib 70mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m20
Phase IISTARTEDPhaseII Dasatinib 100mg/Trastuzumab 2mg/kg/Paclitaxel 80mg/m227
Phase IICOMPLETEDDasatinib 100mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m20
Phase IICOMPLETEDDasatinib 140mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m20
Phase IICOMPLETEDDasatinib 70mg + Trastuzumab 2mg/kg + Paclitaxel 80mg/m20
Phase IICOMPLETEDPhaseII Dasatinib 100mg/Trastuzumab 2mg/kg/Paclitaxel 80mg/m211

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01306942/flow